• Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

    11 monthes ago - By News Medical

    Now, a new study published on the preprint server medRxiv in July 2020 reports that an older treatment modality, namely, the use of convalescent antibody-rich plasma, brings down the mortality rate in hospitalized COVID-19 patients by an astonishing 57%. This adds evidence for the use of convalescent plasma in the treatment of high-risk patients.
    Read more ...